XML 45 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 12, 2018
Feb. 03, 2018
Aug. 01, 2017
Feb. 22, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Common stock shares reserved under stock option plan         19,400,765   19,400,765    
Accounts payable         $ 70,667   $ 70,667   $ 61,333
Research and development expense         108,207 $ 144,885 233,318 $ 223,965  
Harmel S. Rayat [Member]                  
Consideration per year for executive office space             1    
Mr. Sierchio [Member]                  
Common stock shares reserved under stock option plan       37,500          
Debt conversion converted instrument shares issued       22,711          
Mr. Sierchio [Member] | Series H [Member]                  
Common stock shares reserved under stock option plan       10,000          
Debt conversion converted instrument shares issued       7,418          
Mr. Sierchio [Member] | Series F [Member]                  
Common stock shares reserved under stock option plan       7,246          
Debt conversion converted instrument shares issued       4,899          
Dr. Gerlach [Member]                  
Accounts payable         8,000   8,000   17,640
Compensation expense for services         8,000 8,460 $ 15,020 18,540  
Dr. Gerlach [Member] | Series A [Member]                  
Common stock shares reserved under stock option plan 480,000                
Debt conversion converted instrument shares issued 457,480                
Mr. Bhogal [Member]                  
Individual owning issue and outstanding share percent             5.00%    
Kenneth Kirkland [Member]                  
Annual retainer payable         6,000   $ 6,000    
Joseph Sierchio [Member]                  
Annual retainer payable         6,000   6,000    
VAM [Member]                  
Compensation expenses for consulting services per year             120,000    
Consulting services expense         23,067 20,400 43,467 40,800  
Jatinder Bhogal [Member]                  
Increased consulting fee, monthly         6,800   6,800    
Pittsburgh Life Sciences Greenhouse [Member] | Corporate Research Agreement [Member]                  
Research and development expense     $ 171,595   42,899   85,798    
Thomas Bold [Member]                  
Common stock shares reserved under stock option plan   60,000              
Debt conversion converted instrument shares issued   44,083              
Thomas Bold [Member] | Chief Financial Officer [Member]                  
Common stock shares reserved under stock option plan   60,000              
Debt conversion converted instrument shares issued   44,086              
Kenneth Kirkland [Member]                  
Common stock shares reserved under stock option plan       50,000          
Debt conversion converted instrument shares issued       41,033          
Kenneth Kirkland [Member] | Equity Option [Member]                  
Common stock shares reserved under stock option plan       50,000          
Debt conversion converted instrument shares issued       41,033          
StemCell Systems [Member]                  
Incurred expenses         13,169 52,830 25,184 106,830  
Satterlee [Member]                  
Legal fees         96,415 $ 77,537 159,362 $ 180,668  
Accounts payable         $ 60,000   $ 60,000   $ 30,000